Drs. Jennifer Doudna and Emmanuelle Charpentier, who won the Dr. Paul Janssen Award for Biomedical Research in 2014, have received the 2020 Nobel Prize in Chemistry. Johnson & Johnson was proud to recognize Doudna and Charpentier in 2014 for their discovery of the CRISPR-Cas9 method of genetic editing, considered one of the most significant breakthroughs in molecular biology in the past decade which has led to a substantial leap in scientists’ ability to manipulate genetic processes and holds promise for significantly advancing drug development.